1. Home
  2. HAFC vs ODTX Comparison

HAFC vs ODTX Comparison

Compare HAFC & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$32.44

Market Cap

972.5M

Sector

Finance

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$20.73

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAFC
ODTX
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
972.5M
875.1M
IPO Year
2000
2025

Fundamental Metrics

Financial Performance
Metric
HAFC
ODTX
Price
$32.44
$20.73
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$32.17
N/A
AVG Volume (30 Days)
253.1K
173.5K
Earning Date
04-21-2026
N/A
Dividend Yield
3.75%
N/A
EPS Growth
22.44
N/A
EPS
1.54
N/A
Revenue
$270,165,000.00
N/A
Revenue This Year
$18.65
N/A
Revenue Next Year
$7.28
N/A
P/E Ratio
$21.10
N/A
Revenue Growth
15.28
N/A
52 Week Low
$22.85
$15.10
52 Week High
$33.50
$23.08

Technical Indicators

Market Signals
Indicator
HAFC
ODTX
Relative Strength Index (RSI) 55.04 56.19
Support Level $31.45 $15.10
Resistance Level $32.70 N/A
Average True Range (ATR) 0.43 1.74
MACD 0.02 0.15
Stochastic Oscillator 76.77 56.51

Price Performance

Historical Comparison
HAFC
ODTX

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: